Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products Questions and Answers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 23, 2024
July 23, 2024
f791f37f-3382-48a9-8fcb-f27046ac94a4
Related Documents
Drug Master Files Guidance for Industry
Guidance DocumentNovember 15, 2019Center for Drug Evaluation and Research
Labeling for Biosimilar and Interchangeable Biosimilar Products
Guidance DocumentSeptember 18, 2023Center for Drug Evaluation and Research
Drug Abuse and Dependence Section of Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry
Guidance DocumentJuly 1, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox